Moran Timothy P. sold 3,192 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. at $29.56 for −$94.4k on Nov 3, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Business Officer
Chief Business Officer
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$94,352.01Shares × reported price
Shares traded
3,192Common Shares
Price per share
$29.56Reported price. Read footnotes for ranges.
% of reported position traded
4.81%This security and ownership context
Holdings after
63,153Direct
Trade date
Nov 3, 2026Sell
Filed
Nov 5, 2026, 5:41 PM ET2-day reporting delay
Accession
0001193125-26-450260Code S · Transaction 393923
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 66,345 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

KMTS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
KMTS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −3.9%1w ago +5.1%1d ago +4.5%
Returns since7d +0.3%30d90d180d1y

Footnotes in full

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $29.5583 to $29.5595. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.